InvestorsHub Logo
icon url

sokol

06/24/21 8:00 AM

#316990 RE: plexrec #316985

Eli Lilly (LLY) – The drugmaker’s shares surged 8.7% in the premarket after Lilly’s Alzheimer’s treatment received “breakthrough therapy” designation from the Food and Drug Administration. The designation means the treatment may show substantial improvement over existing therapies and qualifying it for expedited development and approval.
icon url

pcguy

06/24/21 8:06 AM

#316993 RE: plexrec #316985

Hmm, competition gets breakthrough MC falls. Market share lowered? How does that impact calculations for AVXL market share?